SCHEMBL897321

SCHEMBL897321

CS(=O)(=O)OCCF

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1734242 0.83
SCHEMBL30752540 0.83
SCHEMBL27291510 0.81 TSHR (0.75)
Ethane Dimethane Sulfonate SCHEMBL1336145 0.81 USP2 (0.75)
SCHEMBL7904019 0.79 TSHR (0.71)
SCHEMBL2552496 0.79 TSHR (0.71)
SCHEMBL302015 0.77
SCHEMBL2065150 0.77
Ethane Dimethane Sulfonate SCHEMBL4140371 0.75 USP2 (0.67)
SCHEMBL12211326 0.75

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 197 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260108497-A1 OXAZOLE COMPOUND AND PHARMACEUTICAL COMPOSITION OTSUKA PHARMACEUTICALC., LTD. (JP) 2026-04-23 US disclosed
US-20260078117-A1 COMPOUNDS AND METHODS OF USE TANGO THERAPEUTICS INC (US) 2026-03-19 US disclosed
US-20250188110-A1 SPECIFIC SMALL MOLECULE INHIBITORS THAT BLOCK KMT9 METHYLTRANSFERASE ACTIVITY AND FUNCTION ALBERT-LUDWIGS-UNIVERSITÄT FREIBURG (DE) 2025-06-12 US disclosed
US-12304907-B2 Compounds and methods of use TANGO THERAPEUTICS, INC. (US) 2025-05-20 US disclosed
US-12264154-B2 Compounds and methods of use TANGO THERAPEUTICS, INC. (US) 2025-04-01 US disclosed
US-12100809-B2 Non-aqueous liquid electrolyte and non-aqueous liquid electrolyte secondary battery MITSUBISHI CHEMICAL CORPORATION (JP) 2024-09-24 US disclosed
US-20240279219-A1 COMPOUNDS AND METHODS OF USE TANGO THERAPEUTICS, INC. 2024-08-22 US disclosed
US-20240228478-A1 COMPOUNDS AND METHODS OF USE TANGO THERAPEUTICS, INC. 2024-07-11 US disclosed
US-20240228478-A1 COMPOUNDS AND METHODS OF USE TANGO THERAPEUTICS, INC. 2024-07-11 US disclosed
EP-4384519-A1 SPECIFIC SMALL MOLECULE INHIBITORS THAT BLOCK KMT9 METHYLTRANSFERASE ACTIVITY AND FUNCTION Albert-Ludwigs-Universität Freiburg (DE) 2024-06-19 EP disclosed
WO-2003101424-A1 MODIFIED RELEASE PHARMACEUTICAL FORMULATION ASTRAZENECA AB (SE) 2003-12-11 WO disclosed
EP-1347955-A1 NEW MANDELIC ACID DERIVATIVES AND THEIR USE AS THROBIN INHIBITORS AstraZeneca AB (SE) 2003-10-01 EP disclosed
US-6620812-B2 Such as 1-(N,N-dimethylsulfamoyl)-3-(2-methyl-3-chloroindol-1-yl)sulfonyl-1,2,4 -triazole NISSAN CHEMICAL INDUSTRIES, LTD. (JP) 2003-09-16 US disclosed
WO-2003000293-A1 PHARMACEUTICAL FORMULATION ASTRAZENECA AB (SE) 2003-01-03 WO disclosed
US-20020103243-A1 Sulfamoyl compounds and agricultural and horticultural fungicides NISSAN CHEMICAL INDUSTRIES, LTD. (JP) 2002-08-01 US disclosed
WO-2002044145-A1 NEW MANDELIC ACID DERIVATIVES AND THEIR USE AS THROBIN INHIBITORS ASTRAZENECA AB (SE) 2002-06-06 WO disclosed
US-6350748-B1 1-(SULFAMOYL)-3-(SULFONYL)-1,2,4-TRIAZOLE DERIVATIVES NISSAN CHEMICAL INDUSTRIES LTD. (JP) 2002-02-26 US disclosed
EP-1031571-A1 SULFAMOYL COMPOUNDS AND AGRICULTURAL OR HORTICULTURAL BACTERICIDE Nissan Chemical Industries, Ltd. (JP) 2000-08-30 EP disclosed
US-5012004-A Ether compounds and their production, and insecticidal and/or acaricidal compositions containing them SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 1991-04-30 US disclosed
EP-0315370-A2 Ether compounds and their production, and insecticidal and/or acaricidal compositions containing them SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 1989-05-10 EP disclosed